Bone cancer pain and the role of RANKL/OPG

Journal of Musculoskeletal Neuronal Interactions

Volumn 4, Issue 3, 2004, Pages 293-300

  Clohisy, Denis R ^a   Mantyh, P W ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Bone cancer; Osteolysis; Osteoprotegerin; Pain

Indexed keywords

CYTOKINE; DYNORPHIN; IMMUNOGLOBULIN FC FRAGMENT; NARCOTIC AGENT; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PROSTAGLANDIN E2; PROTEIN C FOS; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR KAPPA B; UNCLASSIFIED DRUG;

ALLODYNIA; ANALGESIA; BONE CANCER; BONE DESTRUCTION; BONE DEVELOPMENT; BONE DISEASE; BONE METASTASIS; CANCER PAIN; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MECHANISM; EXPERIMENTAL MODEL; HUMAN; NOCICEPTIVE STIMULATION; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOLYSIS; PATHOPHYSIOLOGY; PROTEIN FUNCTION; REVIEW; SARCOMA; STEM CELL; STROMA CELL; TUMOR CELL;

BONE NEOPLASMS; CARRIER PROTEINS; GLYCOPROTEINS; HUMANS; MEMBRANE GLYCOPROTEINS; OSTEOPROTEGERIN; PAIN; RANK LIGAND; RECEPTOR ACTIVATOR OF NUCLEAR FACTOR-KAPPA B; RECEPTORS, CYTOPLASMIC AND NUCLEAR; RECEPTORS, TUMOR NECROSIS FACTOR;

EID: 8644289302     PISSN: 11087161     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (16)

1. Clohisy DR, Le CT, Cheng EY, Dykes DC, Thompson RC Jr. Evaluation of the feasibility of and results of measuring health-status changes in patients undergoing surgical treatment for skeletal metastases. J Orthop Res 2000; 18:1-9.
2. Wacnik PW, Eikmeier LJ, Ruggles TR, Ramnaraine ML, Walcheck BK, Beitz AJ, Wilcox GL. Functional interactions between tumor and peripheral nerve: morphology, algogen identification, and behavioral characterization of a new murine model of cancer pain. J Neurosci 2001; 21:9355-9366.
3. Wacnik PW, Kehl LJ, Trempe TM, Ramnaraine ML, Beitz AJ, Wilcox GL. Tumor implantation in mouse humerus evokes movement-related hyperalgesia exceeding that evoked by intramuscular carrageenan. Pain. 2003; 101:175-186.
4. Schwei MJ, Honore P, Rogers SD, Salak-Johnson JL, Fink MP, Ramnaraine ML, Clohisy DR, Mantyh PW. Neurochemical and cellular reorganization of the spinal cord in a murine model of bone cancer pain. J Neurosci 1999; 19:10886-10897.
5. Medhurst SJ, Walker K, Bowes M, Kidd BL, Glatt M, Muller M, Hattenberger M, Vaxelaire J, O'Reilly T, Wotherspoon G, Winter J, Green J, Urban L. A rat model of bone cancer pain. Pain 2002; 96:129-140.
6. Clohisy DR, Ogilvie CM, Carpenter RJ, Ramnaraine ML. Localized, tumor-associated osteolysis involves the recruitment and activation of osteoclasts. J Orthop Res 1996; 14:2-6.
7. Clohisy DR, Ogilvie CM, Ramnaraine ML. Tumor osteolysis in osteopetrotic mice. J Orthop Res 1995; 13:892-897.
8. Clohisy DR, Ramnaraine ML, Scully S, Qi M, Van G, Tan HL, Lacey DL. Osteoprotegerin inhibits tumor-induced osteoclastogenesis and bone tumor growth in osteopetrotic mice. J Orthop Res 2000; 18:967-976.
9. Sabino MA, Ghilardi JR, Jongen JL, Kevser CP, Luger NM, Mach DB, Peters CM, Rogers SD, Schwei MJ, de Felipe C, Mantyh PW. Simultaneous reduction in cancer pain, bone destruction, and tumor growth by selective inhibition of cyclooxygenase-2. Cancer Res 2002; 62:7343-7349.
10. Honore P, Menning PM, Rogers SD, Nichols ML, Mantyh PW. Neurochemical plasticity in persistent inflammatory pain. Prog Brain Res 2000:129:357-363.
11. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, Elliott R, Colombero A, Elliot G, Scully S, Hsu H, Sullivan J, Hawkins N, Davy E, Capparelli C, Eli A, Qian YX, Kaufman S, Sarosi I, Shalhoub V, Senaldi G, Guo J, Delaney J, Boyle WJ. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998; 93:165-176.
12. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell, Boyle WJ. Osteoprotegerin: a novel secreted protein involved in the regulation of bone density [see comments]. Cell 1997; 89:309-319.
13. Honore P, Luger NM, Sabino MA, Schwei MJ, Rogers SD, Mach DB, O'Keefe PF, Ramnaraine ML, Clohisy DR, Mantyh PW. Osteoprotegerin blocks bone cancer-induced skeletal destruction, skeletal pain and pain-related neurochemical reorganization of the spinal cord [In Process Citation]. Nat Med 2000; 6:521-528.
14. Luger NM, Honore P, Sabino MA, Schwei MJ, Rogers SD, Mach DB, Clohisy DR, Mantyh PW. Osteoprotegerin diminishes advanced bone cancer pain. Cancer Res 2001; 61:4038-4047.
15. Goblirsch M, Mathews W, Lynch C, Alaei P, Gerbi BJ, Mantyh PW, Clohisy DR. Radiation treatment decreases bone cancer pain, osteolysis and tumor size. Radiat Res 2004; 161:228-234.
16. Walker K, Medhurst SJ, Kidd BL, Glatt M, Bowes M, Patel S, McNair K, Kesingland A, Green J, Chan O, Fox AJ, Urban LA. Disease modifying and anti-nociceptive effects of the bisphosphonate, zoledronic acid in a model of bone cancer pain. Pain 2002; 100:219-229.